The Northern Health Science Alliance (NHSA) and the innovation arm of the Israeli Government have signed a memorandum of understanding in a bid to accelerate global innovation in health and life sciences.
The MoU was signed this week at the British Ambassador’s residence near Tel Aviv, by Dr Séamus O’Neill, chief executive of the NHSA, and Dror Bin, CEO of the Israel Innovation Authority.
It builds on four years of collaboration between Israel and the NHSA, facilitated by the UK Israel Tech Hub at the British Embassy in Israel, and renews a pledge to work together to tackle major healthcare challenges.
Through an existing partnership with the UK Israel Tech hub, the NHSA, a partnership of leading NHS (National Health Service) hospitals, universities, and academic health science networks across the North of England, has worked with more than 150 Israeli companies to explore bringing their technologies to the UK.
The deal aims to further strengthen the relationship which will drive jobs, investment, and innovative healthcare into the North of England.
O’Neill said: “The MoU is a fantastic step forward in our strategic partnership with Israel and it builds on the solid foundations of our work to date. We are proud to represent the North of England’s thriving life science sector and demonstrate that the North is very much open for business.
“By bringing international healthcare and industry partners together, we have a truly unique opportunity to share knowledge, develop cutting-edge innovations, drive investment in life-sciences and improve the health and wealth of our region.”
Bin added: “It is a great pleasure to collaborate and strengthen our partnership with the Northern Health Science Alliance. Israel and the UK have a proven track record in health innovation and excellence in life science, making our two countries naturally aligned to accelerate advancements. As part of our international pilot program, the ability to conduct experiments and tests in leading health institutions such as the NHSA member hospitals will create a win-win situation for fostering innovation, creating business opportunities and achieve major medical developments while improving patient care in both countries.”
Israel is known globally as the ‘start-up’ nation, with the most start-ups per capita in the world.